Juan Rigoberto
Tejedo Huaman

Foto de Juan Rigoberto

Foto de Fermín

Fermín
Sánchez-Guijo

Fermín Sánchez-Guijo-rekin lankidetzan egindako argitalpenak (3)

2021

Efficacy and safety of intramuscular administration of allogeneic adipose tissue derived and expanded mesenchymal stromal cells in diabetic patients with critical limb ischemia with no possibility of revascularization: study protocol for a randomized controlled double-blind phase II clinical trial (The NOMA Trial)
Trials, Vol. 22, Núm. 1

2020

Corrigendum: Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus (Frontiers in Immunology, (2019), 10, 10.3389/fimmu.2019.01151)
Frontiers in Immunology

2019

Cost-effective, safe, and personalized cell therapy for critical limb ischemia in type 2 diabetes mellitus
Frontiers in Immunology, Vol. 10, Núm. JUN